Hunan Er Kang Pharmaceutical (300267) — Free Cash Flow Generation Index
Hunan Er Kang Pharmaceutical (300267) has a Free Cash Flow Generation Index of 0.74x as of June 2023. Free cash flow of CN¥128.88 Million represents 1% of operating cash flow (CN¥174.55 Million). Explore Hunan Er Kang Pharmaceutical capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hunan Er Kang Pharmaceutical Free Cash Flow Generation Index (2008–2024)
Historical FCF Generation Index trend for Hunan Er Kang Pharmaceutical across 17 annual periods. For the full cash flow conversion analysis, see how efficiently does Hunan Er Kang Pharmaceutical generate cash.
Annual Free Cash Flow Generation for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year Free Cash Flow Generation Index for Hunan Er Kang Pharmaceutical. Check 300267 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.17x | CN¥-28.91 Million | CN¥166.69 Million | CN¥195.60 Million | ▲ +71.3% |
| 2023 | -0.60x | CN¥-89.77 Million | CN¥148.42 Million | CN¥238.19 Million | ▼ -258.1% |
| 2022 | 0.38x | CN¥107.53 Million | CN¥281.02 Million | CN¥173.49 Million | ▲ +113.8% |
| 2021 | -2.77x | CN¥-256.65 Million | CN¥92.68 Million | CN¥349.33 Million | ▼ -15.7% |
| 2020 | -2.39x | CN¥-427.36 Million | CN¥178.53 Million | CN¥605.89 Million | ▼ -1407.8% |
| 2019 | 0.18x | CN¥81.60 Million | CN¥445.82 Million | CN¥364.21 Million | ▼ -16.5% |
| 2018 | 0.22x | CN¥27.17 Million | CN¥123.89 Million | CN¥96.72 Million | ▼ -64.7% |
| 2017 | 0.62x | CN¥428.30 Million | CN¥689.11 Million | CN¥258.92 Million | ▼ -81.5% |
| 2016 | 3.36x | CN¥1.63 Billion | CN¥486.50 Million | CN¥1.15 Billion | ▲ +59.8% |
| 2015 | 2.10x | CN¥1.09 Billion | CN¥518.96 Million | CN¥570.53 Million | ▼ -47.6% |
| 2014 | 4.01x | CN¥702.81 Million | CN¥175.38 Million | CN¥527.42 Million | ▲ +84.6% |
| 2013 | 2.17x | CN¥378.20 Million | CN¥174.22 Million | CN¥203.98 Million | ▼ -42.2% |
| 2012 | 3.75x | CN¥315.31 Million | CN¥84.02 Million | CN¥231.28 Million | ▲ +137.6% |
| 2011 | 1.58x | CN¥119.59 Million | CN¥75.72 Million | CN¥43.87 Million | ▼ -37.6% |
| 2010 | 2.53x | CN¥107.52 Million | CN¥42.47 Million | CN¥65.05 Million | ▼ -13.6% |
| 2009 | 2.93x | CN¥29.82 Million | CN¥10.18 Million | CN¥19.64 Million | ▼ -95.2% |
| 2008 | 60.81x | CN¥12.83 Million | CN¥211.00K | CN¥12.62 Million | — |